Fresh Tracks Therapeutics

Fresh Tracks Therapeutics is a company listed under the stock ticker FRTX (US).

View the org chart displaying its 16 main executives

Most searched biographies at Fresh Tracks Therapeutics

• Andrew Sklawer, Chief Executive Officer
• Reginald Hardy, Chairman of the Board of Directors
• Vijay Samant, Director

Create your alert
to follow the executive moves at Fresh Tracks Therapeutics.

Fresh Tracks Therapeutics has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Fresh Tracks Therapeutics

Social media about Fresh Tracks Therapeutics

• Fresh Tracks Therapeutics on Wikipedia, Google News & Yahoo Finance
• Fresh Tracks Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Andrew Sklawer

Call Fresh Tracks Therapeutics at +1 786...

View the org chart

Register to receive your alert

Report an error